Eswar Therapeutics Private Limited, a active private limited company, was established on 05 April 2017 in Chandigarh, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304CH2017PTC041467. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 140 professional, Its leadership includes Kashmiri Lal Khunger (Director), Vikram Khungar (Managing Director), Raj Khurana (Director). Past directors included Dipty Manchanda, Rajat Kaher, Kashmiri Lal Khunger. It holds ₹5.19 Cr open charges and ₹1.69 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 4-A, Raipur Kalan,, Chandigarh, Chandigarh, 160102.
U24304CH2017PTC041467
041467
05 April 2017
₹0.10 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Eswar Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kashmiri Lal Khunger | Director | 28 Nov 2023 | Current |
| Vikram Khungar | Managing Director | 25 Jan 2019 | Current |
| Raj Khurana | Director | 01 Apr 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Nov 2023 | Past |
| Pramod Abcsdd | Director | 25 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 31 Mar 2025 | Past |
| Pramod Abcsdd | Director | 25 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eswar Therapeutics Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 37.46% increase. The company also saw a substantial improvement in profitability, with a 45.02% increase in profit. The company's net worth Soared by an impressive increase of 50.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Eswar Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹51,862,639.00
₹16,895,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2025 | Indian Overseas Bank | ₹1.20 M | Open |
| 28 Jul 2025 | Hdfc Bank Limited | ₹0.58 M | Open |
| 29 May 2025 | Hdfc Bank Limited | ₹0.72 M | Open |
| 21 Feb 2025 | Hdfc Bank Limited | ₹0.84 M | Open |
| 16 Dec 2024 | Hdfc Bank Limited | ₹0.70 M | Open |
Explore comprehensive loan charge details -
Eswar Therapeutics has a workforce of 140 employees as of Jan 22, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eswar Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eswar Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Indian Overseas Bank amounted to Rs. 1.20 M with Charge ID 101174374 was registered on 30 Aug 2025. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.58 M with Charge ID 101135228 was registered on 28 Jul 2025. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 0.72 M with Charge ID 101104160 was registered on 29 May 2025. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.84 M with Charge ID 101052220 was registered on 21 Feb 2025. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.70 M with Charge ID 101030587 was registered on 16 Dec 2024. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.75 M with Charge ID 101021699 was registered on 23 Oct 2024. was completed.
The CIN of Eswar Therapeutics Private Limited is U24304CH2017PTC041467.
Eswar Therapeutics Private Limited is headquartered at Plot No. 4-A, Raipur Kalan,, Chandigarh, Chandigarh, 160102.
Eswar Therapeutics Private Limited was incorporated on 05 April 2017.
The current directors of Eswar Therapeutics Private Limited are
The primary industry of Eswar Therapeutics Private Limited is Trade.
Eswar Therapeutics Private Limited is unlisted.
The authorized capital of Eswar Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Eswar Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX